MK-0431/ONO-5435 Phase III Clinical Study - Glimepiride add-on Study for Patients with Type 2 Diabetes Mellitus -

Authors
Category Primary study
JournalJapan Primary Registry Network
Year 2006
INTERVENTION: Intervention name : MK‐0431/ONO‐5435 Dosage And administration of the intervention : Oral CONDITION: Type 2 Diabetes Mellitus PRIMARY OUTCOME: Efficacy, Safety INCLUSION CRITERIA: The target population is the outpatients >=20 years of age with type 2 diabetes mellitus (male and female) who have inadequate glycemic control on diet/exercise therapy and glimepiride as monotherapy.
Epistemonikos ID: 24d30e42cd6faea7883463743d2db15e0fa6f0d3
First added on: Aug 21, 2024